I disagree - I believe we're in a very low point in the cycle, I'd describe the current state as a relative dark age for AAS.
From the recent takeover of Balkan Pharmaceuticals (and the gutting of its synthetic AAS manufacturing), to the Russian Federation legislation prohibiting non-prescription sale of rhGH even prior to this Ukraine situation that has literally made them a worldwide pariah and closed to trade (Russia was an important source country for pharmaceutical anabolic agents), to the nascent intentions of other important source countries (once firmly under the Russian federation's sphere of influence) to join the EU and adopt its comprehensive regulatory scheme (e.g., Moldova, Bulgaria).
The 1980s were the pinnacle of legal and widespread commercial availability of pharmaceutical androgens (the 1960s-70s were important for the research and development of novel anabolic/androgenic steroids and the work done towards dissociating the two properties). The 1990s ushered in prohibition and the WADA mandate against AAS. The 2000s offered some glimmers of hope, during the Designer Steroid Era (THG, 4-diols, 19-nor-diols, 17alpha-methyl analogues, 1-Testo) with the likes of Patrick Arnold and other chemists applying their skills to development of novel anabolic compounds. The early 2010s were a positive inflection point, in the market forces that spurred Chinese export of raws & in the US, the "anti-aging" clinic.
I'd characterize the 2020s (characterized by internet gurus, widespread balkanization of information behind paywalls, Reddit, YouTube, fragmentation and data overload; rise of the smartphone experts; TRT) as the worst time since immediately post-ORD.